Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting
NCT01163604
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
114
Enrollment
OTHER
Sponsor class
Conditions
CVD
Interventions
DRUG:
Argatroban
DRUG:
non-argatroban treated group
Sponsor
Jinling Hospital, China